Feasibility of high-throughput sequencing in clinical routine cancer care: lessons from the cancer pilot project of the France Genomic Medicine 2025 plan

Background Whole exome sequencing and RNA sequencing (WES/RNASeq) should now be implemented in the clinical practice in order to increase access to optimal care for cancer patients. Providing results to Tumour Boards in a relevant time frame—that is, compatible with the clinical pathway—is crucial....

Full description

Bibliographic Details
Main Authors: Simone Mathoulin-Pélissier, Antoine Italiano, Anne Boland, Jean-François Deleuze, Helene Blons, Pierre Laurent-Puig, Carine Bellera, Céline Auzanneau, Delphine Bacq, Marlène Boucheix, Aurélien Bourdon, Emmanuelle Chollet, Christine Chomienne, Christelle Delmas, Derek Dinart, Hélène Espérou, Flore Geillon, Damien Geneste, Delphine Jean, Emmanuel Khalifa, Yec'han Laizet, Franck Lethimonnier, Claire Lévy-Marchal, Carlo Lucchesi, Carine Malle, Pierre Mancini, Vincent Meyer, Palomares Marie-Ange, Géraldine Perkins, Sabrina Sellan-Albert, Isabelle Soubeyran, Cédric Wallet
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:ESMO Open
Online Access:https://esmoopen.bmj.com/content/5/4/e000744.full